Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Hay, G. Kannourakis (2002)
A time to kill: viral manipulation of the cell death program.The Journal of general virology, 83 Pt 7
C. Gregory, C. Dive, S. Henderson, Christopher Smith, Gwyn Williams, J. Gordon, A. Rickinson (1991)
Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosisNature, 349
John Kerr, G. Gobe, C. Winterford, B. Harmon (1995)
Anatomical methods in cell death.Methods in cell biology, 46
Nancy Thornberry, Y. Lazebnik (1998)
Caspases: enemies within.Science, 281 5381
H. Ishii, G. Gobe, T. Joshita, Y. Kurabayashi, Y. Hosomura, T. Kameya (1997)
Analysis of apoptosis morphology in Epstein-Barr virus positive and negative Burkitt's lymphoma cells.Archives of histology and cytology, 60 2
Brendan D'Souza, M. Rowe, D. Walls (2000)
The bfl-1 Gene Is Transcriptionally Upregulated by the Epstein-Barr Virus LMP1, and Its Expression Promotes the Survival of a Burkitt's Lymphoma Cell LineJournal of Virology, 74
K. Hennessy, S. Fennewald, E. Kieff (1985)
A third viral nuclear protein in lymphoblasts immortalized by Epstein-Barr virus.Proceedings of the National Academy of Sciences of the United States of America, 82 17
N. Mueller‐Lantzsch, G. Lenoir, M. Sauter, K. Takaki, J. Béchet, C. Kuklik-Roos, D. Wunderlich, G. Bornkamm (1985)
Identification of the coding region for a second Epstein‐Barr virus nuclear antigen (EBNA 2) by transfection of cloned DNA fragments.The EMBO Journal, 4
Sabine Violette, L. Poulain, E. Dussaulx, D. Pépin, A. Faussat, J. Chambaz, J. Lacorte, C. Staedel, T. Lesuffleur (2002)
Resistance of colon cancer cells to long‐term 5‐fluorouracil exposure is correlated to the relative level of Bcl‐2 and Bcl‐XL in addition to Bax and p53 statusInternational Journal of Cancer, 98
P. Zinzani, M. Tani, A. Molinari, V. Stefoni, E. Zuffa, L. Alinari, A. Gabriele, F. Bonifazi, M. Salvucci, S. Tura, M. Baccarani (2002)
Ifosfamide, epirubicin and etoposide regimen as salvage and mobilizing therapy for relapsed/refractory lymphoma patients.Haematologica, 87 8
R. Ambinder, Maryann, '. Mullen, Y. Chang, G. Hayward, S. Diane, '. Hayward (1991)
Functional domains of Epstein-Barr virus nuclear antigen EBNA-1Journal of Virology, 65
H. Knecht, C. Berger, S. Rothenberger, B. Odermatt, P. Brousset (2001)
The Role of Epstein-Barr Virus in Neoplastic TransformationOncology, 60
G. Bryson, B. Harmon, R. Collins (1994)
A flow cytometric study of cell death: Failure of some models to correlate with morphological assessmentImmunology and Cell Biology, 72
J. Kenney, M. Guinness, T. Curiel, J. Lacy (1998)
Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells.Blood, 92 5
P. Farrell (1998)
Signal transduction from the Epstein-Barr virus LMP-1 transforming protein.Trends in microbiology, 6 5
K. Takada (2001)
Role of Epstein-Barr virus in Burkitt's lymphoma.Current topics in microbiology and immunology, 258
W. Marshall, C. Yim, E. Gustafson, T. Graf, D. Sage, Katherine Hanify, Louisa Williams, J. Fingeroth, R. Finberg (1999)
Epstein-Barr Virus Encodes a Novel Homolog of the bcl-2 Oncogene That Inhibits Apoptosis and Associates with Bax and BakJournal of Virology, 73
E. Hatzivassiliou, G. Mosialos (2002)
Cellular signaling pathways engaged by the Epstein-Barr virus transforming protein LMP1.Frontiers in bioscience : a journal and virtual library, 7
M. Konopleva, Shourong Zhao, Z. Xie, Harry Segall, A. Younes, D. Claxton, Z. Estrov, S. Kornblau, M. Andreeff (1999)
Apoptosis. Molecules and mechanisms.Advances in experimental medicine and biology, 457
Victoria Frost, Sylvie Delikat, S. Al-Mehairi, Alison Sinclair (2001)
Regulation of p27KIP1 in Epstein-Barr virus-immortalized lymphoblastoid cell lines involves non-apoptotic caspase cleavage.The Journal of general virology, 82 Pt 12
V. Kagan, Y. Tyurina (1998)
Recycling and Redox Cycling of Phenolic AntioxidantsAnnals of the New York Academy of Sciences, 854
S. Lyons, D. Liebowitz (1998)
The roles of human viruses in the pathogenesis of lymphoma.Seminars in oncology, 25 4
A. Rapoport, M. Simons-Evelyn, T. Chen, R. Sidell, S. Luhowskyj, K. Rosell, T. Obrig, D. Hicks, P. Hinkle, M. Nahm, R. Insel, C. Abboud (2001)
Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.Blood cells, molecules & diseases, 27 3
B. Baliga, Sharad Kumar (2002)
Role of Bcl‐2 family of proteins in malignancyHematological Oncology, 20
E. Zhao, Q. Song, S. Cross, I. Misko, S. Lees-Miller, M. Lavin (1998)
Resistance to etoposide‐induced apoptosis in a Burkitt's lymphoma cell lineInternational Journal of Cancer, 77
L. Rao, E. White (1997)
Bcl-2 and the ICE family of apoptotic regulators: making a connection.Current opinion in genetics & development, 7 1
S. Silins, T. Sculley (1995)
Burkitt's lymphoma cells are resistant to programmed cell death in the presence of the epstein‐barr virus latent antigen EBNA‐4International Journal of Cancer, 60
J. Menezes, W. Leibold, G. Klein, G. Clements (1975)
Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.Biomedicine / [publiee pour l'A.A.I.C.I.G.], 22 4
P. Bozko, A. Larsen, E. Raymond, A. Składanowski (2002)
Influence of G2 arrest on the cytotoxicity of DNA topoisomerase inhibitors toward human carcinoma cells with different p53 status.Acta biochimica Polonica, 49 1
R. Tawa, D. Gao, M. Takami, Y. Imakura, K. Lee, H. Sakurai (1998)
Binding affinity of Cu(II)-VP-16 (etoposide) complex and its analogues to DNA and hydroxyl radical generation during DNA strand breaks.Bioorganic & medicinal chemistry, 6 7
L. Cuttle, X. Zhang, Z. Endre, C. Winterford, G. Gobe (2001)
Bcl-X(L) translocation in renal tubular epithelial cells in vitro protects distal cells from oxidative stress.Kidney international, 59 5
Michele Barry, Grant McFadden (1998)
Apoptosis regulators from DNA viruses.Current opinion in immunology, 10 4
(1995)
BV (1995)Anatomical methods in cell death
Epstein-Barr virus (EBV)-infected B cell lymphomas are resistant to apoptosis during cancer development and treatment with therapies. The molecular controls that determine why EBV infection causes apoptosis resistance need further definition. EBV-positive and EBV-negative BJA-B B cell lymphoma cell lines were used to compare the expression of selected apoptosis-regulating Bcl-2 and caspase proteins in EBV-related apoptosis resistance, after 8 hr or 18–24 hr etoposide treatment (80 µM). Apoptosis was quantified using morphology and verified with Hoechst 33258 nuclear stain and electron microscopy. Fluorescence activated cell sorting (FACS) was used to analyse effects on cell cycle of the EBV infection as well as etoposide treatment. Anti-apoptotic Bcl-2 and Bcl-XL, pro-apoptotic Bax, caspase-3 and caspase-9 expression and activation were analysed using Western immunoblots and densitometry. EBV-positive cultures had significantly lower levels of apoptosis in untreated and etoposide-treated cultures in comparison with EBV-negative cultures (p < 0.05). FACS analysis indicated a strong G2/M block in both cell sublines after etoposide treatment. Endogenous Bcl-2 was minimal in the EBV-negative cells in comparison with strong expression in EBV-positive cells. These levels did not alter with etoposide treatment. Bcl-XL was expressed endogenously in both cell lines and had reduced expression in EBV-negative cells after etoposide treatment. Bax showed no etoposide-induced alterations in expression. Pro-caspase-9 and -3 were seen in both EBV-positive and -negative cells. Etoposide induced cleavage of caspase-9 in both cell lines, with the EBV-positive cells having proportionally less cleavage product, in agreement with their lower levels of apoptosis. Caspase-3 cleavage occurred in the EBV-negative etoposide-treated cells but not in the EBV-positive cells. The results indicate that apoptosis resistance in EBV-infected B cell lymphomas is promoted by an inactive caspase-3 pathway and elevated expression of Bcl-2 that is not altered by etoposide drug treatment.
Archives of Virology – Springer Journals
Published: Feb 1, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.